Campbell's Q1 Results Down, Yet Beat Street; Backs FY26 View; To Buy 49% Stake In Italy's La Regina

Campbell's reported weaker GAAP Q1 results—net income $194 million ($0.65/share) versus $218 million a year ago—but delivered adjusted EPS of $0.77, ahead of the $0.73 consensus, as adjusted EBIT fell 11% to $383 million and net sales declined 3.4% to $2.68 billion (organic -1%), roughly in line with estimates. The company reiterated fiscal 2026 guidance of adjusted EPS $2.40–$2.55 (a 12–18% decline vs. prior year and near the $2.45 sell‑side consensus), expects adjusted EBIT to fall 9–13% and organic net sales to be -1% to +1%, and highlighted that guidance excludes an extra week in fiscal 2025 (~2% of sales, $0.06 EPS). Campbell's also agreed to acquire a 49% stake in Italy-based La Regina (Rao’s sauces) for $286 million, expected to close in H2 FY26 and be neutral to the reaffirmed guidance; shares were largely unchanged in premarket trading.

Analysis

Campbell's reported Q1 GAAP net income of $194 million ($0.65/sh) versus $218 million ($0.72/sh) a year ago while adjusted EPS of $0.77 beat the $0.73 consensus; adjusted EBIT declined 11% to $383 million and net sales fell 3.4% to $2.68 billion (organic -1%) driven by lower volume/mix partially offset by favorable net price realization. The company outperformed the sales consensus of $2.66 billion but showed clear margin compression and volume weakness that reduced adjusted gross profit. Campbell's reaffirmed fiscal 2026 guidance of adjusted EPS $2.40–$2.55 (a 12–18% decline from $2.91) roughly centered on the Street $2.45 estimate, and expects adjusted EBIT to decline 9–13% with organic net sales -1% to +1% versus $9.98 billion last year; management notes guidance excludes an extra fiscal week in 2025 that contributed ~2% of sales and $0.06 EPS. The firm agreed to acquire 49% of La Regina (Rao's sauces) for $286 million in two tranches, expected to close in H2 FY26 and be neutral to FY26 guidance; premarket shares were essentially flat at $29.97 (-0.23%), reflecting a mixed investor reception as near-term fundamentals and margin levers remain the primary drivers of valuation.

Key Decisions for Investors

• Maintain a cautious stance on CPB and avoid adding material long exposure until at least one quarter shows stabilization in organic sales and adjusted EBIT, given ongoing volume/mix pressure and margin decline
• Monitor quarterly cadence for organic net sales versus the -1%/+1% guidance band and track adjusted EPS versus the $2.40-$2.55 range (remember the guidance excludes a ~2% extra-week benefit and $0.06 EPS), consider adding on confirmed stabilization or upside surprises
• Treat the 49% La Regina acquisition as strategically positive for premium sauces exposure but financially neutral near term; do not assume meaningful EPS accretion until integration and synergy details are disclosed, consider modest hedges if holding into execution risk